IP Verse

Process For Efficient Purification Of Neutral Human Milk Oligosaccharides (Hmos) From Microbial Fermentation - EP2896628

The patent EP2896628 was granted to CHR Hansen HMO on Sep 19, 2018. The application was originally filed on Jan 20, 2014 under application number EP14151737A. The patent is currently recorded with a legal status of "Revoked".

EP2896628

CHR HANSEN HMO
Application Number
EP14151737A
Filing Date
Jan 20, 2014
Status
Revoked
Sep 27, 2024
Grant Date
Sep 19, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (6)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

NESTLEApr 23, 2020WITHDRAWN
BASFJun 19, 2019ADMISSIBLE
GLYCOMJun 19, 2019WITHDRAWN
GREAVES BREWSTERJun 18, 2019ADMISSIBLE
STRAWMANJun 18, 2019WITHDRAWN
FRIESLANDCAMPINA NEDERLANDJun 12, 2019ADMISSIBLE

Patent Citations (32) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONWO2010115935
EXAMINATIONEP2857410
EXAMINATIONWO2012092160
EXAMINATIONWO2012112777
EXAMINATIONWO2013025104
OPPOSITIONCN101691538
OPPOSITIONEP2013367
OPPOSITIONEP2379708
OPPOSITIONEP2479263
OPPOSITIONEP2526784
OPPOSITIONEP2857410
OPPOSITIONEP2896628
OPPOSITIONEP3141610
OPPOSITIONJPS61271296
OPPOSITIONUS2005069997
OPPOSITIONUS2005211240
OPPOSITIONUS2010248315
OPPOSITIONUS2016333042
OPPOSITIONUS6017433
OPPOSITIONUS6454946
OPPOSITIONWO0024918
OPPOSITIONWO2011016008
OPPOSITIONWO2011150939
OPPOSITIONWO2012069415
OPPOSITIONWO2012112777
OPPOSITIONWO2012122777
OPPOSITIONWO2012160080
OPPOSITIONWO2013182206
OPPOSITIONWO2013185780
OPPOSITIONWO2015106943
OPPOSITIONWO2015150328
SEARCHEP2479263

Non-Patent Literature (NPL) Citations (39) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- SAMAIN ET AL., "Production of O-acetylated and sulfated chitooligosaccharides by recombinant Escherichia coli strains harboring different combinations of nod genes.", J. BIOTECHNOL., (1999), vol. 72, pages 33 - 47-
EXAMINATION- Wataru Sumiyoshi ET AL, "Determination of each neutral oligosaccharide in the milk of Japanese women during the course of lactation", British Journal of Nutrition, (20030101), vol. 89, no. 01, doi:10.1079/BJN2002746, ISSN 0007-1145, pages 61 - 69, XP055199354
OPPOSITION- Anonymous, "Chromatography", Wikipedia, the free encyclopedia, (20190610), URL: https://en.wikipedia.org/wiki/Chromatography, (20190613), XP055615906-
OPPOSITION- Anonymous, "Electrodialysis", Wikipedia, the free encyclopedia, (20140106), URL: https ://en.wikipedia.org/w/index.php?title=Electrodialvsis&oldid=589414103, (20190619), XP055615910-
OPPOSITION- Anonymous, "Product Information Lewatit® S 2568", Lanxess, (20090818), pages 1 - 4, XP055618554-
OPPOSITION- Anonymous, "Product Information Lewatit® S 6368 A", Lanxess, (20111013), pages 1 - 4, XP055618553-
OPPOSITION- "Chapter 18", Rehm H-J, et al., Biotechnology, 2nd ed., VCH , (19930101), pages 469 - 503, XP055706495-
OPPOSITION- "Chapter 1 - Chromatography principles and process development", Ge Healthcare Life Sciences, Multimodal Chromatography Handbook, (20131101), pages 3 - 15, XP093008403-
OPPOSITION- "Chapter 1: Fermentation Technology", STANBURY PF et al, MOLECULAR BIOLOGY AND BIOTECHNOLOGY, Royal Society of Chemistry, (20070000), pages 1 - 24, XP055615822-
OPPOSITION- "Chapter 1: Fermentation Technology", Stanbury P.F., et al., MOLECULAR BIOLOGY AND BIOTECHNOLOGY, Royal Society of Chemistry , (20070101), pages 1 - 24, XP055615822-
OPPOSITION- "Chapter 1 - Introduction", A. BRAITHWAITE et al., Chromatographic Methods, 4th ed., (19850000), pages 1 - 7, XP055612094-
OPPOSITION- "Chapter 1 - Introduction", A. Braithwaite, F.J. Smith, Chromatographic Methods, 4th ed., (19850101), pages 1 - 7, XP055612094-
OPPOSITION- "Chapter 4", Karp Angela, et al., Molecular Tools for Screening Biodiversity, Plants and Animals, CHAPMAN & HALL , (19980101), pages 53 - 59, XP055706481-
OPPOSITION- "Chromatography", JOHN MCMURRY, ORGANIC CHEMISTRY. 6th Ed., Thomson, (20040000), pages 415 - 416, XP055615824-
OPPOSITION- "Downstream Process Technology: An Overview", Krishna Kant Prasad, et al., Downstream Process Technology: A New Horizon In Biotechnology, PH Learning , (20100101), pages 3 - 15, XP055706479-
OPPOSITION- "Effective ion exchange for challenging water-treatment needs", URL: https://www.dupont.com/water/technologies/ion-exchange-ix.html-
OPPOSITION- FARRELL, S et al., "Exploring the potential of electrodialysis", Chemical Engineering Education, (20031200), vol. 37, no. 1, pages 52 - 59, XP055618502-
OPPOSITION- Farrell, S Et Al., "Exploring the potential of electrodialysis", Chemical Engineering Education, (20031201), vol. 37, no. 1, pages 52 - 59, XP055618502-
OPPOSITION- Jennewein Biotechnologie Gmbh, "GRAS Notification for T-Fucosyllactose (T-FL)", GRAS Notice (GRN) No. 571, (20150301), pages 000001-000021, 000282 - 000301, URL: http://wayback.archive-it.org/7993/20171031041333/https://www.fda.gov/downloads/Food/IngredientsPackagingLabeling/GRAS/NoticeInventory/UCM461885.pdf, XP055618524-
OPPOSITION- Perola O. Magalhaes et al, "Methods of Endotoxin Removal from Biological Preparations: a Review", JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, CA , (20070518), vol. 10, no. 3, ISSN 1482-1826, pages 388 - 404, XP007913761-
OPPOSITION- "Sorbents for Chromatography", J D SEADER et al., Separation Process Principles, CHEMICAL AND BIOCHEMICAL OPERATIONS. 3rd Ed., John Wiley & Sons, (20100000), pages 577 - 578, XP055615828-
OPPOSITION- STOCK, R et al., Chromatographic Methods, New York, John Wiley & Sons, Inc.,, (19740000), pages 1-23, 26-31, 40 - 51, XP055618540-
OPPOSITION- "WHO Expert Committee on Specifications for Pharmaceutical Preparations", WHO Technical Report Series, (19990000), pages 1 - 168, URL: http://apps.who.int/medicinedocs/en/d/Jh1792e/18.2.4. 2.html#Jh1792e.18.2.4.2-
OPPOSITION- DROUILLARD et al., "Large-Scale Synthesis of H-Antigen Oligosaccharides by Expressing Helicobacter pylori alpha- 1,2-Fucosyltransferase in Metabolically Engineered Escherichia coli Cells", Angewandte Chemie International Edition, (20060214), vol. 45, no. 11, pages 1778 - 1780, XP055105681
OPPOSITION- Robert J. Linhardt, Helene G. Bazin, "Separation and Purification of Carbohydrates", Glycoscience: Chemistry and Chemical Biology I-III, Berlin, Heidelberg , Springer Berlin Heidelberg , (20010101), pages 63 - 74, doi:10.1007/978-3-642-56874-9_3, ISBN 978-3-642-56874-9, XP055706476
OPPOSITION- T. BUTTLER et al., "Characterization of a sampling unit based on tangential flow filtration for on- line bioprocess monitoring", Analytica Chimica Acta, (19930000), vol. 279, doi:10.1016/0003-2670(93)85063-P, pages 27 - 37, XP026594665
OPPOSITION- Fakhreddin Salehi, "Current and future applications for nanofiltration technology in the food processing", FOOD AND BIOPRODUCTS PROCESSING, GB , (20140401), vol. 92, no. 2, doi:10.1016/j.fbp.2013.09.005, ISSN 0960-3085, pages 161 - 177, XP055369772
OPPOSITION- WANG et al., "Demineralization of soybean oligosaccharides extract from sweet slurry by conventional electrodialysis", Journal of Food Engineering, (20090606), vol. 95, no. 3, pages 410 - 415, XP026467145
OPPOSITION- Wang, Q. ; Ying, T. ; Jiang, T. ; Yang, D. ; Jahangir, M.M., "Demineralization of soybean oligosaccharides extract from sweet slurry by conventional electrodialysis", Journal of Food Engineering, AMSTERDAM, NL, (20091201), vol. 95, no. 3, doi:10.1016/j.jfoodeng.2009.05.024, ISSN 0260-8774, pages 410 - 415, XP026467145
OPPOSITION- Paulina Urrutia, Barbara Rodriguez-Colinas, Lucia Fernandez-Arrojo, Antonio O. Ballesteros, Lorena Wilson, Andres Illanes, Francisco J. Plou, "Detailed Analysis of Galactooligosaccharides Synthesis with B-Galactosidase from Aspergillus oryzae", Journal of Agricultural and Food Chemistry, US , (20130206), vol. 61, no. 5, doi:10.1021/jf304354u, ISSN 0021-8561, pages 1081 - 1087, XP055706491
OPPOSITION- ARTEAGA-CABELLO et al., "Synthesis of 2- FL and LDFT by metabolically engineered E. coli through the fkp gene from Bacteroides fragilis", Program and abstracts for the 2011 Meeting of the Society for Glycobiology / Glycobiology, vol. 2, no. 11, (20111100), page 1499, URL: https://academic.oup.com/glycob/article/21/11/1454/1987828, XP055616744
OPPOSITION- Yu et al., "The principal fucosylated oligosaccharides of human milk exhibit prebiotic properties on cultured infant microbiota", Glycobiology, (20130000), vol. 23, no. 2, pages 169 - 177, XP055275362
OPPOSITION- BAUMGARTNER, F et al., "Construction of Escherichia coli strains with chromosomally integrated expression cassettes for the synthesis of 2′-fucosyllac", Microbial Cell Factories, (20130000), vol. 12, page 40, XP021151035
OPPOSITION- LEVISON, P. R., "Techniques in Process-Scale Ion-Exchange Chromatography", LEVISON, P. R., G. Ganetsos, P.E. Barker, Preparative and Production Scale Chromatography, Marcel Dekker, Inc., (19930000), vol. 61, pages 2pp, 617 - 620, XP055616756
OPPOSITION- "Techniques in Process-Scale Ion-Exchange Chromatography", Levison, P. R., Preparative and Production Scale Chromatography, Marcel Dekker, Inc. , (19930101), pages 617 - 620, doi:10.1201/9780367811150-31, XP055616756
OPPOSITION- EZURE Y. et al., "Manufacturing High Purity Maltose and Maltotetraose from Starch by a Novel and Efficient Procedure Named “Reducing End Modification Method", Biosci. Biotech. Biochem., (19970100), vol. 61, no. 11, pages 1931 - 1933, XP055615831
OPPOSITION- Yohji Ezure, Shigeaki Maruo, Masahiko Kojima, Tomonori Sakai, Hirofumi Yamamoto, Noriyuki Tachikake, Hirotsugu Ogawa, Masaya Toda, "Manufacturing High Purity Maltose and Maltotetraose from Starch by a Novel and Efficient Procedure Named “Reducing End Modification Method”", Bioscience, Biotechnology, and Biochemistry, JP , (19970101), vol. 61, no. 11, doi:10.1271/bbb.61.1931, ISSN 0916-8451, pages 1931 - 1933, XP055615831
OPPOSITION- NEWBURG et al., "Human Milk Oligosaccharides and Synthetic Galactosyloligosaccharides Contain 3'-, 4-, and 6'-Galactosyllactose and Attenuate Inflammation in Human T84, NCM-460, and H4 Cells and Intestinal Tissue Ex Vivo", J Nutr., (20160200), vol. 146, no. 2, doi:10.3945/jn.115.220749, pages 358 - 67, XP055632669
SEARCH- ALBERMANN C ET AL, "Synthesis of the milk oligosaccharide 2'-fucosyllactose using recombinant bacterial enzymes", CARBOHYDRATE RESEARCH, PERGAMON, GB, (20010823), vol. 334, no. 2, doi:10.1016/S0008-6215(01)00177-X, ISSN 0008-6215, pages 97 - 103, XP004298614 [Y] 1-12 * page 102, paragraph 1 - column 2 *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents